ValSource is proud to announce Senior Consultant Tiffany Baker has been awarded the PDA James Agalloco Award, which honors her outstanding performance in education as a PDA Training and Research Institute (TRI) instructor.

ValSource is proud to receive the Gold Safety Award for Quality Assurance from Highwire. This prestigious award is presented to companies registering a safety score of 85-94% in Hirewire’s Independent Safety Assessment Program, which reviews a company’s historic and current safety performance. The program provides a thorough, objective, and consistent evaluation of company performance so clients and contractors can identify, monitor, and mitigate risks more effectively. The results provide a strong indicator of how a contractor values
safety and serve as a reliable predictor of future performance.

This is the 4th episode in our series focused on Advanced Therapeutic Medical Products (ATMPs) that includes cell and gene therapies. Specifically, we’ll be discussing ATMP/CGT and working with third parties. Providing their knowledge are 3 ValSource colleagues who have a wealth of experience: Ryan Murray, Steven Langille, and Darius Pillsbury.

You may select three officers and three board members who will take seats on the PDA Board of Directors. Vote soon, the election runs from Sept 7 – Nov 15. Vote for ValSource Senior Microbiology Consultant Marc Glogovsky for PDA Board of Directors!

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today proudly announced the hire of Jessica Chiaruttini, Ph.D. Jessica’s extensive FDA experience and diverse skill set brings added value to ValSource’s growing team of talent.

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced the hire of Beth Fulton, MS as a consultant. Beth’s experience and diverse skill set brings added value to ValSource’s growing team of talent. Kelly Waldron, Quality Business Unit Manager, noted, “Beth is a welcome addition to our team of quality consultants. Her quality and compliance mindset and keen risk-based thinking will ensure we continue to exceed the expectations of our clients.”

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced a new Calibration Metrology Group. The new ValSource team not only provides standard calibration services but solves overlaps in instrument validation and calibration processes by providing both services in one.

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced the hire of Virginia Andreotti-Jones as a consultant. Virginia’s experience and diverse skill set brings added value to ValSource’s growing team of talent.

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today proudly announced two leadership team members will lead a live, interactive training webinar hosted by Pharma Webinars, “Are You Ready for Annex 1? Points to Consider When Doing an Annex 1 Self-Assessment.”

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today proudly announced Tiffany Baker, MBA, Consultant, ValSource Inc, is scheduled to speak at the 2021 PDA Remote Audits & Inspections Workshop on April 8, 2021.

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced the hire of Angelica Welch as a consultant. Angie’s experience and diverse skill set brings added value to ValSource’s growing team of talent.

ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today proudly announced several members of its Senior Consulting leadership team were recognized by the Parenteral Drug Association (PDA) for their achievements and contributions to the PDA and the healthcare product industry. These awards will be presented at the 2021 PDA Annual Meeting on Advancing People, Connecting Data, and Evolving Manufacturing Technologies, at the 2021 Award Ceremony on March 24, 2021.

Stephen E. Langille, Ph.D., Senior Microbiology Consultant at ValSource, Tiffany Baker, MBA, Consultant at ValSource, Amanda McFarland, MS, Senior Consultant at ValSource, Danica Brown, Consultant at ValSource, and Christopher J. Smalley, MBA, MS, Ph.D., Compounding Pharmacist Advisor at Valsource are each scheduled to speak at the conference at sessions that include Improving, Modernizing, Transforming – Process Validation Gets a (much needed) Upgrade and Modern Toolkits for Enhancing People Competency, Improving Data Integrity through Culture Metrics.

DOWNINGTOWN, Pa. (Nov. 16, 2020) — ValSource, Inc, a consulting and advisory service provider for the regulated biological, medical device, and pharmaceutical industries, today announced the addition of three new directors to the corporate board. The new ValSource directors include Diane Blumenthal, Katherine Oates, and Robert Radie, each bringing a diverse skill set to the leadership team.

Senior Microbiology Consultant Stephen Langille was recently elected to the United States Pharmacopeia’s Compounding Expert Committee for the 2020-2025 cycle. (USP). The role of this Expert Committee is to develop new and revise existing general chapters related to physical analysis (e.g., particles, powders, rheology).